The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
At least one recognised startup in every State and UT; spread across over 80% of districts
Karkinos Healthcare has demonstrated exceptional dedication to privacy, setting a commendable example for businesses navigating the complexities of the digital landscape
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Demonstrate significant bleed reduction in hemophilia A and B
South Asia’s largest Trade Fair for pharma brought together over 50,000 visitors from across the globe, more than 1,500 exhibitors showcasing 10,000+ products and representation from over 80 countries
Subscribe To Our Newsletter & Stay Updated
